• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为霍奇金淋巴瘤表现的消失性胆管综合征。

Vanishing bile duct syndrome as a presentation of Hodgkin's lymphoma.

机构信息

Internal Medicine, University of Missouri Kansas City, Kansas City, Missouri, USA.

Medicine, Section of Hematology and Oncology, University of Missouri Kansas City School of Medicine, Kansas City, Missouri, USA.

出版信息

BMJ Case Rep. 2024 May 21;17(5):e256818. doi: 10.1136/bcr-2023-256818.

DOI:10.1136/bcr-2023-256818
PMID:38772873
Abstract

Vanishing bile duct syndrome is an uncommon condition characterised by the progressive loss and disappearance of bile ducts. It is an acquired form of cholestatic liver disease presenting with hepatic ductopenia (loss of >50% bile ducts in the portal areas). We present a case of vanishing bile duct syndrome as a presentation of Hodgkin's lymphoma who was treated with standard-of-care chemotherapy-doxorubicin, bleomycin, vinblastine and dacarbazine (along with brief administration of rituximab), which led to complete response and normalisation of liver function.

摘要

消失性胆管综合征是一种不常见的疾病,其特征为胆管进行性丧失和消失。它是一种获得性胆汁淤积性肝病,表现为肝内胆管减少(门脉区>50%的胆管丧失)。我们报告一例以霍奇金淋巴瘤为表现的消失性胆管综合征,患者接受了标准治疗方案的化疗(多柔比星、博来霉素、长春碱和达卡巴嗪),并短暂给予利妥昔单抗治疗,这导致完全缓解和肝功能正常化。

相似文献

1
Vanishing bile duct syndrome as a presentation of Hodgkin's lymphoma.作为霍奇金淋巴瘤表现的消失性胆管综合征。
BMJ Case Rep. 2024 May 21;17(5):e256818. doi: 10.1136/bcr-2023-256818.
2
[Hodgkin’s lymphoma-related vanishing bile duct syndrome].[霍奇金淋巴瘤相关的胆管消失综合征]
Orv Hetil. 2021 May 30;162(22):884-888. doi: 10.1556/650.2021.32093.
3
The vanishing bile duct syndrome in a child with Hodgkin disease.一名患有霍奇金病儿童的胆管消失综合征
Med Pediatr Oncol. 2001 Mar;36(3):398-9. doi: 10.1002/mpo.1096.
4
Hodgkin's lymphoma-related vanishing bile duct syndrome: a case report and literature review.霍奇金淋巴瘤相关的消失性胆管综合征:病例报告及文献复习。
Kaohsiung J Med Sci. 2013 Nov;29(11):636-41. doi: 10.1016/j.kjms.2013.05.002. Epub 2013 Aug 9.
5
Superior vena cava syndrome caused by Hodgkin's lymphoma in an adolescent girl.一名青春期女孩因霍奇金淋巴瘤导致上腔静脉综合征。
BMJ Case Rep. 2012 Feb 21;2012:bcr0120125487. doi: 10.1136/bcr.01.2012.5487.
6
Complete remission of paraneoplastic vanishing bile duct syndrome after the successful treatment of Hodgkin's lymphoma: a case report and review of the literature.霍奇金淋巴瘤成功治疗后副肿瘤性胆管消失综合征完全缓解:一例报告并文献复习
BMC Res Notes. 2014 Aug 14;7:529. doi: 10.1186/1756-0500-7-529.
7
Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial.ABVD 方案中省略达卡巴嗪或博来霉素或两者在治疗早期有利霍奇金淋巴瘤(GHSG HD13)中的应用:一项开放标签、随机、非劣效性试验。
Lancet. 2015 Apr 11;385(9976):1418-27. doi: 10.1016/S0140-6736(14)61469-0. Epub 2014 Dec 22.
8
A successful initiation of treatment of Hodgkin's lymphoma with adriamycin-bleomycin-vinblastine-dacarbazine dose reduction in a patient with fulminant hepatic failure and co-infection with human immunodeficiency virus and hepatitis B.在一名暴发性肝衰竭合并人类免疫缺陷病毒和乙型肝炎感染的患者中,阿霉素-博来霉素-长春碱-达卡巴嗪剂量减少治疗霍奇金淋巴瘤取得成功。
J Oncol Pharm Pract. 2022 Mar;28(2):479-485. doi: 10.1177/10781552211040182. Epub 2021 Sep 30.
9
Vanishing bile duct syndrome occurring after high-dose chemotherapy and autologous peripheral stem cell transplantation in a patient with Hodgkin's disease.一名霍奇金病患者在接受大剂量化疗和自体外周干细胞移植后出现的胆管消失综合征。
Ann Hematol. 2002 Jan;81(1):57-8. doi: 10.1007/s00277-001-0406-7. Epub 2001 Dec 13.
10
Presentation of Hodgkin's lymphoma with Ophelia syndrome.霍奇金淋巴瘤伴奥菲莉亚综合征表现。
J Clin Oncol. 2007 May 1;25(13):1802-3. doi: 10.1200/JCO.2006.10.0578.

引用本文的文献

1
Vanishing Bile Duct Syndrome: A Differential Diagnosis for Painless Jaundice.消失胆管综合征:无痛性黄疸的鉴别诊断
Cureus. 2024 Sep 5;16(9):e68724. doi: 10.7759/cureus.68724. eCollection 2024 Sep.